APA

Detaint D., Aegerter P., Tubach F., Hoffman I., Plauchu H., Dulac Y., Faivre L. O., Delrue M., Collignon P., Odent S., Tchitchinadze M., Bouffard C., Arnoult F., Gautier M., Boileau C. & Jondeau G. (20101015). Rationale and design of a randomized clinical trial (Marfan Sartan) of angiotensin II receptor blocker therapy versus placebo in individuals with Marfan syndrome. : Archives of cardiovascular diseases.

Chicago

Detaint Delphine, Aegerter Philippe, Tubach Florence, Hoffman Isabelle, Plauchu Henri, Dulac Yves, Faivre Laurence Olivier, Delrue Marie-Ange, Collignon Patrick, Odent Sylvie, Tchitchinadze Maria, Bouffard Catherine, Arnoult Florence, Gautier Mathieu, Boileau Catherine and Jondeau Guillaume. 20101015. Rationale and design of a randomized clinical trial (Marfan Sartan) of angiotensin II receptor blocker therapy versus placebo in individuals with Marfan syndrome. : Archives of cardiovascular diseases.

Harvard

Detaint D., Aegerter P., Tubach F., Hoffman I., Plauchu H., Dulac Y., Faivre L. O., Delrue M., Collignon P., Odent S., Tchitchinadze M., Bouffard C., Arnoult F., Gautier M., Boileau C. and Jondeau G. (20101015). Rationale and design of a randomized clinical trial (Marfan Sartan) of angiotensin II receptor blocker therapy versus placebo in individuals with Marfan syndrome. : Archives of cardiovascular diseases.

MLA

Detaint Delphine, Aegerter Philippe, Tubach Florence, Hoffman Isabelle, Plauchu Henri, Dulac Yves, Faivre Laurence Olivier, Delrue Marie-Ange, Collignon Patrick, Odent Sylvie, Tchitchinadze Maria, Bouffard Catherine, Arnoult Florence, Gautier Mathieu, Boileau Catherine and Jondeau Guillaume. Rationale and design of a randomized clinical trial (Marfan Sartan) of angiotensin II receptor blocker therapy versus placebo in individuals with Marfan syndrome. : Archives of cardiovascular diseases. 20101015.